Kenneth J. Hillan
CIK 1600359 · Chief Therapeutics Officer · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
35
Lifetime Open-Market Net
-$295.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 99,600 | $0.18 | $17.7K | $0 | 6 | 2025-06-16 |
| ZYME | Director | — | $22.88 | — | $0 | 5 | 2023-12-08 |
| Chrome Holding Co. (ME) Delisted | Chief Therapeutics Officer | 237,223 | $0.61 | $143.8K | -$31.9K | 8 | 2023-06-07 |
| Achaogen, Inc. (AKAO) Delisted | See Remarks | 293,336 | — | — | -$244.3K | 12 | 2018-06-29 |
| Relypsa Inc (RLYP) Delisted | Director | 2,250 | — | — | -$19.6K | 4 | 2016-09-02 |
Recent Filings · Page 2 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-22 | Chrome Holding Co. (ME) Delisted | Tax (F) | −4,628 | -$15.4K | EDGAR |
| 2022-06-02 | Chrome Holding Co. (ME) Delisted | Tax (F) | −4,627 | -$13.0K | EDGAR |
| 2022-03-01 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2022-02-11 | Chrome Holding Co. (ME) Delisted | Grant (A) | +214,091 | $0 | EDGAR |
| 2021-05-07 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2021-03-01 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +8,200 | $0 | EDGAR |
| 2020-09-11 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2020-05-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2019-05-08 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2018-06-29 | Achaogen, Inc. (AKAO) Delisted | Exer (M) | +177,935 | $1.08M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.